pulsechas
label
methionin
longterm
label
glycoprotein
coronaviru
shown
acquir
olink
oligosaccharid
twostep
process
min
synthesi
protein
nacetylgalactosamin
ad
follow
min
later
addit
galactos
sialic
acid
give
matur
oligosaccharid
sequenc
addit
confirm
analyz
oligosaccharid
bound
el
form
use
gel
filtrat
column
intracellular
locat
first
step
determin
ex
ploit
temperatur
sensit
viru
releas
viru
normal
bud
first
smooth
membran
compart
lie
rough
endoplasm
reticulum
ci
side
golgi
stack
tooz
et
al
viru
assembl
appear
enter
golgi
stack
addit
nacetylgalactosamin
unaffect
although
addit
galactos
sialic
acid
inhibit
result
strongli
suggest
addit
nacetylgalactosamin
occur
bud
compart
morpholog
similar
transit
element
vesicl
p
rotein
export
endoplasm
reticulum
er
move
cisterna
golgi
stack
direct
correct
destin
either
insid
outsid
cell
rothman
griffith
simon
pfeffer
rothman
mani
protein
undergo
seri
posttransl
modif
transport
includ
addit
oligosaccharid
either
nlink
asparagin
olink
serin
threonin
sequenc
modif
coval
bound
oligosaccharid
reflect
movement
protein
one
compart
next
transport
pathway
addit
modif
nlink
oligosaccharid
extens
investig
review
kornfeld
kornfeld
much
less
known
addit
olink
oligosaccharid
simplest
common
type
indirect
evid
construct
olink
glycan
twostep
process
addit
nacetylgalactosamin
galnac
preced
galactos
gal
sialic
acid
nana
addit
last
two
sugar
almost
certainli
occur
tran
part
golgi
stack
cum
et
al
elhamm
kornfeld
propos
site
addit
first
sugar
howev
rang
rough
er
strou
protein
assembl
abbrevi
use
paper
er
endoplasm
reticulum
gal
galactos
galnac
nacetylgalactosamin
memmet
methioninefre
modifi
eagl
medium
mous
hepat
viru
strain
nana
nacetylneuramin
acid
sialic
acid
triton
ci
part
golgi
stack
entri
point
protein
left
er
cum
et
al
roth
medial
part
niemann
et
al
elhamm
kornfeld
final
transgolgi
cisterna
johnson
spear
evid
support
idea
galnac
ad
either
protein
leav
er
sever
reason
proven
difficult
locat
site
first
sugar
addit
absenc
combin
biochem
morpholog
studi
oglycosyl
singl
protein
must
rank
import
envelop
protein
coronaviru
mous
hepat
viru
strain
contain
olink
oligosaccharid
therefor
good
model
studi
addit
olink
sugar
bud
intracellularli
viral
membran
protein
need
bud
holm
et
al
b
rottier
et
al
synthesi
rough
er
protein
transport
smooth
membran
compart
rough
er
golgi
stack
accumul
allow
nucleocapsid
cytoplasm
bind
result
format
virion
holm
et
al
tooz
et
al
virion
follow
secretori
pathway
cell
holm
et
al
tooz
et
al
virion
contain
addit
second
envelop
glycoprotein
essenti
infect
sturman
incorpor
yet
undefin
stage
bud
transport
virion
intracellular
compart
fusogen
also
transport
cellular
membran
plasma
membran
help
spread
infect
induc
fusion
infect
cell
contigu
uninfect
cell
sturman
holm
reduc
temperatur
proven
use
tool
analyz
compart
exocyt
transport
pathway
differ
step
differenti
sensit
protein
accumul
differ
stage
led
morpholog
character
compart
similar
coronaviru
bud
compart
found
babi
hamster
kidney
bhk
cell
infect
semliki
forest
viru
incub
sarast
kuismanen
exploit
reduc
temperatur
prevent
movement
coronaviru
analyz
oligosaccharid
bound
arrest
viru
also
present
evid
show
bud
compart
morpholog
criteria
clearli
relat
transit
element
transit
vesicl
classic
defin
exocrin
pancreat
cell
work
palad
colleagu
caro
palad
jamieson
palad
creat
process
infect
exist
uninfect
cell
physiolog
function
compart
appear
addit
galnac
impli
contain
enzym
add
sugar
serin
threonin
residu
nacetyl
propag
sac
cell
tooz
et
al
titer
plaqu
titrat
confluent
monolay
l
cell
follow
infect
h
monolay
overlaid
carboxymethyl
cellulos
incub
h
co
incub
monolay
fix
stain
mm
triscl
buffer
ph
contain
wtvol
crystal
violet
volvol
formaldehyd
volvol
meoh
wtvol
kariinen
et
al
sac
cell
grown
coverslip
infect
fix
formaldehyd
label
tooz
et
al
use
either
mab
direct
gift
koolen
utrecht
osterhu
nation
institut
public
health
bilthoven
holland
antibodi
direct
endogen
golgi
protein
burk
et
al
second
antibodi
rabbit
antimous
kindli
provid
dr
b
burk
european
molecular
biolog
laboratori
heidelberg
frg
affin
purifi
conjug
rhodamin
fix
label
coverslip
mount
moviol
view
epifluoresc
zeiss
photomicroscop
iii
infect
sac
cell
dish
fix
dehydr
embed
epon
previous
detail
tooz
et
al
antibodi
use
immunoperoxidas
label
standard
protocol
tooz
et
al
infect
sac
cell
dish
either
puls
label
contin
label
methionin
wash
three
time
methioninefre
modifi
eagl
medium
memmet
cell
label
tci
methionin
min
longer
period
cell
chase
variou
time
addit
growth
medium
contain
mgml
methionin
normal
amount
quantit
number
el
molecul
label
methionin
defin
specif
activ
use
cell
werewash
ice
cold
pb
extract
triton
pb
contain
tgml
phenylmethylsulfonyl
fluorid
pmsf
insolubl
residu
remov
centrifug
g
min
deterg
phase
enrich
el
glycoprotein
isol
detergentsolubl
extract
describ
bordier
medium
contain
label
virion
collect
layer
onto
continu
sucros
gradient
describ
spaan
et
al
virion
harvest
gradient
centrifug
h
ga
el
glycoprotein
extract
virion
use
detail
elenrich
deterg
extract
cell
viru
solubil
reduc
sampl
buffer
alkyl
green
et
al
fraction
sdspage
use
run
gel
stack
gel
maizel
incorpor
radioact
methionin
determin
tca
precipit
man
novelli
equal
count
load
onto
lane
unless
otherwis
indic
gel
fix
use
wtvol
tca
treat
dri
expos
kodak
xs
film
quantit
methionin
incorpor
glycoprotein
fluorogram
expos
kodak
film
fluorograph
use
locat
band
fluorogram
excis
piec
rehydr
incub
ml
volvol
mm
h
scintil
fluid
ml
rotiz
firma
roth
karlsruh
frg
ad
sampl
cool
count
gel
piec
equival
size
area
contain
sampl
treat
similarli
use
provid
blank
typic
experiment
valu
methioninelabel
cell
solubil
ripa
buffer
mm
trishci
ph
naci
wtvol
triton
wtvol
sd
wtvol
sodium
deoxychol
contain
cocktail
proteas
inhibitor
tgml
pmsf
lagml
leupeptin
ixgml
antipain
mm
benzamidin
uml
trasylol
extract
centrifug
ga
supernat
treat
polyclon
antiserum
rais
triton
extract
gradientpurifi
virion
tooz
stanley
overnight
incub
immun
complex
immobil
pansorbin
h
wash
three
time
ripa
buffer
one
half
sampl
digest
muml
neuraminidas
clostridium
perfringen
mm
sodium
acet
buffer
ph
conmin
mm
h
digest
immun
complex
wash
well
mm
trishcl
buffer
ph
contain
proteas
inhibitor
cocktail
sampl
togeth
untreat
one
prepar
fraction
sdspage
growth
medium
chang
h
infect
cultur
either
left
shift
time
period
indic
cultur
treat
h
infect
proteinas
k
remov
virion
infect
stock
bound
surfac
temperatur
incub
nd
none
detect
undilut
supernat
infect
sac
cell
cell
label
h
laciml
glucosamin
mem
contain
normal
concentr
glucos
itgml
volvol
dialyz
fc
mm
hepe
buffer
ph
mm
sodium
pyruv
ixgml
penicillin
streptomycin
cell
solubil
ripa
buffer
el
glycoprotein
immunoprecipit
describ
procedur
describ
adapt
cum
et
al
sdspage
individu
glycosyl
form
excis
dri
gel
rehydr
digest
pronas
final
concentr
mgml
glycopeptid
elut
gel
piec
use
hzo
eluat
conmin
glycopeptid
lyophil
resuspend
glycopeptid
acetyl
treatment
acet
anhydrid
baenzig
kornfeld
desalt
amberlit
mix
bed
resin
mild
alkalin
hydrolysi
eluat
lyophil
resuspend
sodium
carbon
ph
treat
equal
volum
mm
naoh
incub
h
describ
niemann
klenk
neutral
glacial
acet
acid
oligosaccharid
pass
dowex
column
elut
volvol
acet
acid
peak
fraction
contain
oligosaccbarid
pool
lyophil
borat
remov
repeat
evapor
methanol
oligosaccharid
final
resuspend
distil
final
recoveri
iabel
materi
onehalf
materi
appli
directli
mesh
column
cm
equilibr
run
ph
remaind
first
digest
neuraminidas
vibrio
cholera
final
concentr
uml
mm
sodium
acet
buffer
ph
contain
mm
naci
mm
incub
toluen
atmospher
h
niemann
klenk
reaction
stop
boil
sampl
lyophil
resuspend
itl
distil
h
applic
column
prepar
chines
hamster
ovari
cho
clone
cell
infect
vesicular
stomat
viru
describ
featherston
et
al
glycopeptid
prepar
dolicollink
oligosaccharid
pellet
releas
endoglycosidas
h
digest
l
galnacitol
prepar
reduct
galnac
gener
suppli
dr
w
gielen
univers
cologn
frg
li
et
al
galnacitol
prepar
acid
hydrolysi
udpnacetyld
galactosamin
cum
et
al
follow
reduct
li
et
al
sac
cell
releas
progeni
viru
exponenti
begin
h
start
infect
continu
cell
lyse
releas
molecul
virion
parallel
releas
viru
particl
consist
known
depend
bud
glycoprotein
tooz
holm
behnk
observ
preliminari
morpholog
studi
virion
assembl
accumul
within
infect
cell
instead
releas
confirm
observ
infect
sac
cell
incub
h
releas
infecti
viru
measur
plaqu
titrat
assay
next
h
cultur
either
kept
shift
ad
precaut
cell
treat
min
proteinas
k
h
infect
remov
virion
infect
inoculum
still
remain
cell
surfac
ensur
releas
progeni
particl
measur
infect
cell
label
h
infect
methionin
memmet
contain
ixgpi
cold
methionin
end
label
period
cell
treat
mgml
proteinas
k
min
proteinas
k
neutral
pmsf
cell
pellet
supernat
pool
medium
collect
cell
proteinas
k
treatment
label
virion
purifi
sucros
gradient
cell
virion
subject
extract
follow
sdspage
count
per
minut
form
el
detect
fluorographi
includ
lower
molecular
weight
form
el
gener
proteinas
k
digest
rottier
et
al
rottier
et
al
rottier
et
al
elimin
possibl
cell
releas
larg
number
noninfecti
particl
would
score
infect
assay
el
contain
viru
particl
releas
cell
quantit
infect
cell
label
h
infect
pss
methionin
medium
collect
label
virion
associ
plasma
membran
remov
proteinas
k
treatment
pool
virion
medium
sdspage
fluorographi
virion
purifi
medium
band
excis
count
shown
tabl
ii
drop
temperatur
label
period
inhibit
releas
virionassoci
mark
contrast
howev
total
amount
synthes
reduc
upon
shift
temperatur
tabl
ii
total
protein
synthesi
infect
uninfect
cell
averag
decreas
time
period
discrep
observ
decreas
releas
infecti
virion
tabl
fivefold
decreas
releas
virionassoci
tabl
ii
may
mean
noninfecti
particl
assembl
releas
howev
favor
altern
explan
name
proteinas
k
treatment
damag
cell
lead
artifactu
releas
intracellular
virion
medium
collect
cell
without
proteinas
k
treatment
amount
methioninelabel
virionassoci
limit
detect
fluorographi
sdspage
data
shown
furthermor
electron
microscop
studi
thin
section
infect
cell
incub
h
infect
reveal
extracellular
virion
associ
plasma
membran
see
fig
data
show
synthesi
continu
almost
normal
releas
medium
virion
dramat
inhibit
determin
site
accumul
virion
combin
biochem
morpholog
techniqu
use
h
infect
sac
cell
puls
min
methionin
chase
presenc
excess
unlabel
methionin
min
fig
show
proport
unglycosyl
protein
eu
lane
convert
min
chase
intermedi
form
higher
molecular
weight
ei
lane
min
chase
lane
matur
form
em
experi
consist
three
distinct
polypeptid
differ
molecular
mass
kd
three
form
alway
detect
fig
lane
experi
vari
small
amount
two
addit
higher
molecular
mass
form
resolv
observ
increas
molecular
mass
must
due
addit
olink
oligosaccharid
holm
et
al
niemann
klenk
rottier
et
al
known
posttransl
modif
el
intermedi
form
ei
howev
previous
detect
heterogen
matur
form
resolv
fig
seen
previou
work
viru
propag
differ
cell
line
eg
niemann
et
al
determin
sugar
composit
oligosaccharid
bound
form
infect
cell
label
h
infect
sugar
expect
present
olink
oligosaccharid
extract
subject
sdspage
follow
fluorographi
expect
elu
unglycosyl
form
el
label
fig
cf
lane
lane
galactos
nacetylmannosamin
specif
metabol
precursor
gal
nana
respect
neutra
leblond
monaco
robbin
found
label
elm
form
fig
cf
lane
lane
presenc
nana
elm
also
confirm
treatment
methioninelabel
neuraminidas
elm
polypeptid
alon
reduc
molecular
mass
form
migrat
slightli
slower
ei
fig
lane
assum
olink
oligosaccharid
compos
galgalnac
matur
form
known
contain
two
type
olink
oligosaccharid
disialyl
form
niemann
et
al
intermedi
form
eli
label
glucosamin
fig
lane
fig
lane
ei
also
label
gal
fig
lane
base
known
structur
oligosaccharid
data
indic
galnac
like
sugar
present
ei
form
journal
cell
biolog
volum
puls
label
min
iscil
methionin
puls
label
chase
min
immunoprecipit
sampl
divid
half
either
lane
incub
without
neuraminidas
digest
buffer
lane
muml
neuraminidas
digest
buffer
overnight
equal
volum
load
onto
lane
major
digest
product
neuraminidas
treatment
confirm
intermedi
form
result
addit
galnac
infect
cell
label
h
infect
glucosamin
viru
purifi
medium
solubil
pool
label
cell
also
solubil
phase
extract
immunoprecipit
resolv
sdspage
follow
fluorographi
polypeptid
excis
gel
two
group
lower
elu
eli
higher
elm
molecular
mass
form
analyz
column
chromatographi
alkalin
hydrolysi
releas
oligosaccharid
side
chain
oligosaccharid
releas
lower
molecular
mass
form
must
origin
eli
sinc
elu
label
glucosamin
fig
lane
shown
figur
singl
peak
ran
posit
galnacitol
alcohol
deriv
galnac
sensit
treatment
neuraminidas
fig
b
two
predomin
oligosaccharid
elm
peak
fig
c
b
correspond
di
alyat
monosialyl
oligosaccharid
treatment
neuraminidas
b
convert
quantit
nana
fig
peak
c
galnacitol
fig
peak
sugar
well
galnacitol
fig
peak
e
present
untreat
sampl
fig
c
like
degrad
product
alkalin
hydrolysi
taken
togeth
experi
describ
far
show
galnac
first
sugar
ad
protein
follow
later
time
gal
nana
examin
effect
decreas
temperatur
glycosyl
el
infect
cultur
label
rain
chase
either
fig
rain
chase
form
detect
cell
extract
fig
lane
rain
decreas
amount
form
label
fig
lane
presum
label
molecul
incorpor
virion
transport
cell
cultur
shift
chase
period
glycosyl
block
intermedi
form
fig
lane
block
maintain
min
chase
detect
decreas
either
unglycosyl
intermedi
form
fig
compar
lane
lane
min
chase
infect
cultur
return
min
amount
elu
eli
form
decreas
fig
lane
form
el
excis
gel
quantit
result
present
fig
expect
fig
decreas
incub
temperatur
reduc
percentag
increas
percentag
surprisingli
percentag
ei
remain
approxim
constant
temperatur
separ
experi
absolut
amount
form
measur
shown
fig
b
decreas
matur
form
elm
accompani
increas
unglycosyl
form
elo
chang
amount
intermedi
form
ei
relat
block
oligosaccharid
matur
intracellular
local
el
infect
cell
label
indirect
immunofluoresc
microscopi
use
mab
el
h
infect
restrict
perinuclear
region
fig
pattern
label
similar
extens
observ
antibodi
specif
endogen
golgi
protein
data
shown
h
infect
syncytia
develop
contain
sever
hundr
nuclei
concomitantli
becam
detect
rough
er
throughout
cytoplasm
fig
b
late
time
mab
also
label
patch
cell
surfac
fig
b
label
attribut
releas
progeni
virion
known
remain
close
associ
cell
surfac
duboisdalcq
et
al
contrast
cell
shift
h
infect
incub
h
infect
label
within
cell
remain
restrict
perigolgi
region
although
area
intens
label
increas
seen
h
infect
fig
c
furthermor
neither
rough
er
surfac
cell
incub
h
infect
label
el
observ
impli
accumul
perinuclear
region
incub
virion
transport
cell
incub
syncitia
also
fail
enlarg
significantli
viral
envelop
glycoprotein
respons
viralinduc
cell
fusion
sturman
holm
attribut
lack
growth
syncytia
failur
transport
virion
cell
may
also
reduct
transport
plasma
membran
membran
glycoprotein
independ
transport
virion
investig
inhibit
enlarg
syncytia
revers
expand
rapidli
within
h
return
data
shown
bud
progeni
virion
occur
membran
high
concentr
viral
el
spike
glycoprotein
first
detect
thin
section
electron
microscop
h
infect
earli
time
first
site
bud
smooth
membran
compart
complex
irregular
vesiculotubular
morpholog
fig
compart
refer
bud
compart
alway
close
associ
cisterna
rough
er
includ
transit
element
usual
alway
bud
compart
also
juxtapos
ci
side
golgi
stack
see
fig
sinc
membran
bud
compart
smooth
site
synthesi
insert
membran
furthermor
report
previous
bud
compart
contain
cytochem
marker
rough
er
tooz
et
al
conclud
initi
site
accumul
level
support
bud
distinct
smooth
membran
compart
usual
found
transit
element
rough
er
usual
lie
golgi
complex
examin
singl
serial
section
show
distinct
compart
also
exist
uninfect
cell
also
invari
associ
transit
element
rough
er
golgi
stack
comparison
fig
show
bud
compart
dilat
infect
uninfect
cell
part
doubt
result
bud
virion
diam
compart
infect
cell
although
made
extens
morphometr
analys
bud
compart
clear
examin
singl
serial
section
volum
surfac
area
smaller
either
golgi
complex
rough
er
begin
h
infect
rough
er
becom
site
bud
virion
progress
virus
bud
accumul
compart
tooz
et
al
tooz
et
al
virion
also
seen
increasingli
rim
golgi
cisterna
postgolgi
vesicl
transport
viru
cell
surfac
golgi
cisterna
becom
distend
eventu
vesicul
h
infect
cell
lysi
start
tooz
et
al
unpublish
observ
contrast
cultur
shift
h
infect
infect
cell
surviv
least
h
h
infect
golgi
stack
retain
morpholog
integr
virion
seen
within
golgi
cisterna
postgolgi
transport
vesicl
fig
seen
outsid
cell
associ
plasma
membran
hand
rough
er
contain
massiv
accumul
virion
fig
morpholog
observ
indic
littl
transport
virion
golgi
stack
beyond
believ
block
virion
transport
prevent
disrupt
golgi
stack
one
cytopath
effect
infect
also
observ
cell
infect
uukuniemi
viru
bunyaviru
bud
intracellular
membran
gahmberg
et
al
use
immunoperoxidas
label
techniqu
mab
aminotermin
epitop
tooz
stanley
determin
level
resolut
electron
microscop
membran
contain
differ
time
infect
two
temperatur
h
infect
rough
er
label
bud
compart
label
expect
indirect
immunofluoresc
microscopi
also
distinct
label
stack
cistern
membran
golgi
complex
fig
reaction
product
found
lumen
side
compart
fig
consist
fact
mab
recogn
aminotermin
epitop
el
continu
incub
increas
number
label
compart
includ
rough
er
tooz
et
al
label
golgi
cisterna
h
infect
indic
reach
cistern
membran
integr
membran
protein
howev
absenc
bud
virion
directli
golgi
cisterna
earli
time
infect
tooz
et
al
fig
indic
amount
membran
threshold
concentr
necessari
bud
clearli
threshold
detect
immunoperoxidas
techniqu
involv
enzymat
amplif
shift
time
h
infect
h
incub
lower
temperatur
label
pattern
use
im
show
bud
compart
juxtapos
golgi
stack
therefor
compar
bud
compart
uninfect
cell
shown
fig
bud
compart
close
golgi
stack
shown
fig
note
irregular
form
compart
distens
accumul
virion
frequent
part
cytoplasm
face
bud
compart
bristl
coat
appear
site
fusion
small
vesicl
arrowhead
b
e
coat
differ
morpholog
coat
typic
coat
vesicl
open
arrow
c
orci
et
al
shown
immunocytochemistri
coat
type
associ
golgi
membran
lack
clathrin
bar
vtm
journal
cell
biolog
volum
figur
serial
section
bud
compart
uninfect
sac
cell
uninfect
cell
compart
arrowhead
found
close
associ
transit
element
region
rough
er
arrow
often
bud
compart
occur
transit
element
golgi
stack
sometim
figur
show
adjac
golgi
stack
situat
absenc
smooth
cisgolgi
membran
easier
trace
bud
compart
serial
section
note
complex
irregular
morpholog
bud
compart
absenc
ribosom
membran
micrograph
shown
nine
section
si
continu
ribbon
section
nm
thick
exampl
therefor
bud
compart
extend
depth
nm
micrograph
magnif
bar
lam
munoperoxidas
techniqu
similar
seen
h
infect
reaction
product
seen
bud
compart
golgi
cisterna
data
shown
least
two
posttransl
modif
result
chang
molecular
mass
coronaviru
el
first
involv
addit
galnac
min
synthesi
molecular
mass
increas
kd
would
correspond
addit
three
gainac
molecul
sequenc
armstrong
et
al
show
four
potenti
glycosyl
site
olink
oligosaccharid
amino
terminu
protein
maximum
three
use
niemann
et
al
min
later
gal
nana
ad
give
varieti
matur
form
explain
variat
number
galnac
residu
modifi
heterogen
matur
sialyl
oligosaccharid
addit
gal
nana
probabl
occur
transgolgi
complex
necessari
enzym
found
carlson
et
al
sadler
et
al
rearick
et
al
elhamm
kornfeld
drug
inhibit
transport
golgi
complex
quinn
et
al
tartakoff
et
al
inhibit
format
matur
oligosaccharid
structur
found
monensin
cccp
inhibit
glycosyl
manner
essenti
ident
inhibit
tooz
result
must
howev
interpret
caution
drug
often
imposs
distinguish
inhibit
transport
direct
inhibit
enzym
add
sugar
pathway
taken
newli
synthes
complic
intracellular
bud
viru
simplest
one
envisag
move
bud
compart
nucleocapsid
bind
bud
move
secretori
pathway
part
matur
virion
howev
immunoperoxidas
label
show
clearli
golgi
complex
present
virion
also
everi
cistern
membran
see
fig
amount
golgi
membran
estim
catalyt
natur
peroxidas
techniqu
late
viral
infect
must
lower
need
support
bud
viru
accumul
golgi
membran
infect
may
repres
dead
end
caus
leakag
bud
compart
nucleocapsid
unabl
trap
bud
virion
idea
support
find
transport
beyond
golgi
stack
cellular
membran
tooz
stanley
tooz
et
al
altern
cistern
may
repres
genuin
part
matur
pathway
el
may
move
golgi
cisterna
back
bud
compart
particip
bud
reaction
seem
unlik
howev
attempt
show
movement
er
protein
golgi
stack
back
fail
yamamoto
et
al
brand
et
al
therefor
reason
assum
transport
membran
er
bud
compart
reach
concentr
suffici
allow
bud
first
time
thereaft
incorpor
envelop
progeni
virion
move
golgi
stack
thenc
cell
surfac
small
amount
leak
golgi
stack
independ
virion
infect
progress
amount
el
synthes
increas
unpublish
data
time
bud
progeni
virion
directli
lumen
rough
er
begin
increas
interpret
indic
rate
insert
rough
er
membran
be
exceed
rate
transport
er
bud
compart
reduc
temperatur
profoundli
inhibit
releas
virion
medium
morpholog
evid
suggest
entri
virion
golgi
complex
inhibit
result
virion
seen
golgi
cisterna
post
golgi
transport
vesicl
golgi
stack
maintain
normal
morpholog
inhibit
virion
transport
accompani
inhibit
termin
glycosyl
would
expect
termin
glycosyl
occur
transgolgi
complex
b
deliv
normal
incorpor
envelop
progeni
virion
rather
integr
protein
cellular
membran
addit
galnac
still
occur
unchang
extent
suggest
sugar
ad
bud
compart
interestingli
amount
contain
galnac
chang
temperatur
reduc
decreas
elm
accompani
increas
correl
increas
bud
rough
er
argu
galnac
ad
rough
er
bud
compart
galnac
ad
either
cotransl
resid
rough
er
membran
increas
amount
eli
form
would
expect
concentr
reach
level
support
bud
compart
also
readili
detect
immunocytochemistri
tooz
et
al
howev
constant
amount
contain
galnac
eli
impli
compart
sugar
ad
limit
capac
smaller
rough
er
morpholog
evid
indic
bud
compart
fulfil
criteria
bud
compart
product
infect
found
uninfect
sac
cell
preliminari
observ
serial
section
rat
exocrin
pancreat
cell
murin
cell
show
peculiar
sac
cell
three
cell
type
bud
compart
found
frequent
close
associ
patch
rough
er
differenti
transit
element
region
juxtapos
ci
side
golgi
apparatu
howev
bud
compart
transit
element
rough
er
sac
cell
restrict
region
also
occur
associ
patch
rough
er
remot
golgi
apparatu
exist
peripher
transit
element
pancreat
cell
long
known
jamieson
palad
observ
togeth
sarast
kuismanen
tartakoff
merisko
et
al
indic
structur
transit
elementtransit
vesicl
region
cell
consider
complex
hitherto
appreci
fig
summar
interpret
result
describ
suggest
galnac
ad
bud
compart
say
enzym
nacetylgalactosaminyltransferas
found
exclus
compart
although
avail
fraction
data
show
restrict
smooth
membran
kim
et
al
ko
raghupathi
hanov
et
al
hanov
et
al
elhamm
kornfeld
one
must
rememb
posit
enzym
infer
posit
substrat
product
subject
certain
strict
criteria
obvious
enzym
locat
pathway
point
substrat
acquir
sugar
exist
site
point
substrat
appear
modifi
substat
may
assum
particular
conform
act
upon
enzym
nacetylgalactosaminyltransferas
could
present
earlier
pathway
bud
compart
may
substrat
reach
bud
compart
altern
mean
detect
modif
may
depend
substrat
conform
presenc
proteinbound
galnac
ci
golgi
detect
lectin
label
roth
may
reflect
addit
sugar
compart
prior
compart
proteinbound
oligosaccharid
inaccess
lectin
possibl
normal
consid
could
explain
larg
otherwis
irreconcil
discrep
locat
assign
nacetylgalactosaminyltransferas
strou
niemann
et
al
cum
et
al
figur
schemat
illustr
first
site
bud
smooth
membran
compart
transit
element
er
golgi
stack
reduc
temperatur
block
entri
virion
golgi
stack
prevent
el
acquir
galactos
sialic
acid
galnac
sugar
probabl
ad
bud
compart
limit
size
distinct
er
golgi
apparatu
johnson
spear
differ
resolv
locat
enzym
use
immunocytochem
techniqu
transport
plasma
membran
envelop
glycoprotein
influenza
viru
sfv
vsv
slow
transmost
golgi
compart
reduc
incub
temperatur
matlin
simon
sarast
kuismanen
fuller
et
al
block
transport
protein
rough
er
golgi
stack
requir
reduct
temperatur
sarast
kuismanen
contrast
lower
incub
temperatur
result
least
reduct
releas
virion
concommitantli
block
complet
oglycosyl
viral
envelop
glycoprotein
shown
transport
particl
bud
compart
golgi
apparatu
thenc
cell
much
cold
sensit
transport
rough
er
envelop
glycoprotein
vsv
sfv
remain
explain
possibl
differ
stem
fact
one
case
whole
virion
transport
viral
glycoprotein
insert
cellular
membran
